SCHEMBL4679974

SCHEMBL4679974

Cc1ccccc1COC(=O)N1CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.55
ALDH1A1 P00352 5/20 0.51
GAA P10253 2/20 0.51
LMNA P02545 2/20 0.50
F13A1 P00488 1/20 0.49
TGM2 P21980 1/20 0.49
TGM1 P22735 1/20 0.49
FNTA P49354 1/20 0.48
FNTB P49356 1/20 0.48
PGGT1B P53609 1/20 0.48
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
MAPT P10636 1/20 0.44
SIGMAR1 Q99720 1/20 0.43
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4679969 0.99 GRIN2B (0.54) GRIN2BALDH1A1GAALMNAF13A1
SCHEMBL23850757 0.87 GRIN2B (0.58) GRIN2BALDH1A1GAALMNAF13A1
SCHEMBL4678523 0.83 L3MBTL1 (0.49) GRIN2BALDH1A1GAALMNAKMT2A
SCHEMBL542695 0.83 ALDH1A1 (0.54) GRIN2BALDH1A1F13A1TGM2TGM1
SCHEMBL4679438 0.83 GRIN2B (0.55) GRIN2BALDH1A1LMNAKMT2AMEN1
Hydrochloric Acid SCHEMBL4682508 0.82 L3MBTL1 (0.48) GRIN2BALDH1A1GAALMNAKMT2A
SCHEMBL8527420 0.82 ABCC1 (0.51) ALDH1A1LMNAKMT2AMEN1NPSR1
Hydrochloric Acid SCHEMBL4684877 0.82 ALDH1A1 (0.53) GRIN2BALDH1A1F13A1TGM2TGM1
Hydrochloric Acid SCHEMBL4684380 0.82 GRIN2B (0.54) GRIN2BALDH1A1LMNAKMT2AMEN1
SCHEMBL31517048 0.81 GRIN2B (0.52) GRIN2BALDH1A1GAALMNAF13A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103108866-A Cyclohexane derivative compound DAIICHI SANKYO CO LTD 2013-05-15 CN disclosed
EP-1343775-B1 PIPERAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-06-04 EP disclosed
CN-1277824-C Piperazine derivatives HOFFMANN LA ROCHE (CH) 2006-10-04 CN disclosed
US-7022707-B2 Piperazine derivatives HOFFMAN-LA ROCHE INC. (US) 2006-04-04 US disclosed
US-20040235859-A1 Novel piperazine derivatives ADAMS DAVID REGINALD (GB) 2004-11-25 US disclosed
CN-1533382-A Piperazine derivatives - 2004-09-29 CN disclosed
EP-1343775-A2 PIPERAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-09-17 EP disclosed
US-20020143020-A1 Novel piperazine derivatives VERNALIS RESEARCH LIMITED (GB) 2002-10-03 US disclosed
WO-2002048124-A2 PIPERAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020143020-A1 Novel piperazine derivatives CYP4B1, UGT1A1, CYP1B1 GRIN2B 668/4885ALDH1A1 4/4885GAA 2841/4885
US-20040235859-A1 Novel piperazine derivatives CYP4B1, UGT1A1, CYP1B1 GRIN2B 668/4885ALDH1A1 4/4885GAA 2841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.